Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities.
about
Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients.A tightly regulated IL-22 response maintains immune functions and homeostasis in systemic viral infection.Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-β in cultured hepatoma cells.Interferon-λ in HCV Infection and Therapy.IFN-λ exerts opposing effects on T cell responses depending on the chronicity of the virus infection.Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells.Albumin fusion of interleukin-28B: production and characterization of its biological activities and protein stability.Impact and regulation of lambda interferon response in human metapneumovirus infectionDysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expressionRole of IFN-ks, IFN-ks related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease.A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus.Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damagesHepatitis B Virus Covalently Closed Circular DNA Formation in Immortalized Mouse Hepatocytes Associated with Nucleocapsid Destabilization.Interferon lambda inhibits dengue virus replication in epithelial cells.The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and Function.Relevance of interleukin-10RB to chronic hepatitis B virus infection and biological activities of interferon-λ and interleukin-22Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID)Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expressionInterferon-lambda in the immune response to hepatitis B virus and hepatitis C virus.HBV life cycle and novel drug targets.Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturation.Interferon stimulated genes and innate immune activation following infection with hepatitis B and C viruses.STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α.Human but not mouse hepatocytes respond to interferon-lambda in vivo.Integrated modeling and analysis of intracellular and intercellular mechanisms in shaping the interferon response to viral infection.Chronic hepatitis B and IL28B rs12979860 polymorphism: preliminary study.Type I and type III interferon-induced immune response: it's a matter of kinetics and magnitude.IL28B rs12979860 polymorphism does not influence outcomes of hepatitis B virus infection.When Hepatitis B Virus Meets Interferons
P2860
Q33734554-6F408088-720F-428C-A5E4-8C3FBEB8B7F9Q33818770-65C27A35-7371-4426-8807-B766B221B2A3Q33988856-5D3EC1D4-CB68-4E93-91E8-A9186620FDB8Q34047500-8B1C0511-090C-4B5A-86C8-5D424DA5E98FQ34147632-1F929562-FD07-4364-BAD3-AA8E54E05D41Q34485130-6BD8ED89-1856-4DD8-97F7-68ECDEBD6273Q34760439-7AEFE391-23EB-4A34-AE5A-15221902C092Q34992701-BD8071AD-313F-4D02-B4D5-0CC302A77FEBQ35126674-CBB24F94-40DA-4336-843A-8FB75CA8F3F1Q35208006-C4FA3450-8BFD-4098-8162-5AD1CED2CF43Q35420938-BF87C14A-C020-4F10-8B2E-247E7AE8AD3CQ35841871-4E23AFAC-BFC6-4BCB-939D-5966D7D32860Q35913871-062B54C3-E9AA-4C4C-B1FC-8ACED0AF6FE3Q36096932-78629FB3-555F-4D52-A5B7-133B41F71664Q36104804-1A5C0CCD-DA9C-432D-A710-E998E2B5FF90Q36695256-E5F16A20-A358-44B7-B277-6DF55CAB037BQ36911822-A8D7EAED-9E34-4853-B885-E1E8E5450A9CQ37272140-AB7DFCFF-0C44-4EB9-BD2F-1EF4204F7602Q37610149-0887C177-D097-40A7-A1B0-49618529173BQ37774371-04E0D5F2-934C-4130-A7CC-A18A9B195757Q37864117-8812614A-B280-472C-8C65-1B7CBF38C1C3Q38180983-2C4A4A22-7823-46A3-B39C-C102F98B4473Q38535876-04AD357F-D7FF-4012-8A30-E78D115F6C46Q38923708-BD87AA66-BCCF-4A87-8A8A-37A234353522Q40419017-38EB01E3-5C5E-405C-B0AC-401156948258Q41904704-2146C329-C46F-42F7-B682-8B0CCEEFFA79Q41919279-642B2963-8831-4960-9F84-150F86F87E28Q42246885-72AEFB27-785E-4498-8968-38721100B78AQ43544761-8D95ABBB-FA5F-47EF-B769-ED823C445E3AQ45360478-EE611E49-1AF5-4C70-BF07-332192AF3207Q56940144-70302C8E-C254-41E1-8A36-537E72447C65
P2860
Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Lambda and alpha interferons i ...... different in vivo activities.
@en
Lambda and alpha interferons i ...... different in vivo activities.
@nl
type
label
Lambda and alpha interferons i ...... different in vivo activities.
@en
Lambda and alpha interferons i ...... different in vivo activities.
@nl
prefLabel
Lambda and alpha interferons i ...... different in vivo activities.
@en
Lambda and alpha interferons i ...... different in vivo activities.
@nl
P2093
P2860
P1433
P1476
Lambda and alpha interferons i ...... different in vivo activities.
@en
P2093
Christopher R Bolen
Esther N Chu
Michael D Robek
Nicole E Pagliaccetti
Steven H Kleinstein
P2860
P304
P356
10.1016/J.VIROL.2010.02.022
P407
P577
2010-03-29T00:00:00Z